Who owns SOLENO THERAPEUTICS INC?
- Ticker: SLNO
- CUSIP Number: 834203309
Tip: Access positions for across all investors
Analyze quarterly positions in Soleno Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Soleno Therapeutics stock
Who bought or sold SOLENO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 8.4M | $360M | 0% | Mar 2024 |
|
| Perceptive Advisors | 3.1M | $124M | 0% | Dec 2023 |
|
| Carlyle | 2.9M | $115M | 25% | Dec 2023 |
|
| Nantahala Capital Management | 2.9M | $115M | 628% | Dec 2023 |
|
| Henderson Group | 2.5M | $102M | 15% | Dec 2023 |
|
| Vanguard Group | 970k | $39M | 1655% | Dec 2023 |
|
| Balyasny Asset Management | 927k | $37M | 102% | Dec 2023 |
|
| venBio Select Advisor | 785k | $32M | 100% | Dec 2023 |
|
| Commodore Capital | 700k | $28M | -21% | Dec 2023 |
|
| Ikarian Capital | 611k | $25M | 14% | Dec 2023 |
|
| Frazier Life Sciences Management | 465k | $19M | 0% | Dec 2023 |
|
| Samlyn Capital | 302k | $12M | 100% | Dec 2023 |
|
| Emerald Advisers | 252k | $10M | 1% | Dec 2023 |
|
| Wellington Management Company | 213k | $8.6M | 100% | Dec 2023 |
|
| Emerald Mutual Fund Advisers, Trust | 201k | $8.1M | 0% | Dec 2023 |
|
| Allspring Global Investments Holdings | 104k | $4.4M | 100% | Mar 2024 |
|
| 683 Capital Management | 87k | $3.5M | 0% | Dec 2023 |
|
| J. Goldman & Co | 73k | $2.9M | 11% | Dec 2023 |
|
| Goldman Sachs Group | 69k | $2.8M | 100% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 61k | $2.5M | 162% | Dec 2023 |
|
| Bank of America Corporation | 58k | $2.3M | 1374% | Dec 2023 |
|
| Cubist Systematic Strategies | 57k | $2.3M | 100% | Dec 2023 |
|
| Jane Street | 46k | $1.8M | 100% | Dec 2023 |
|
| Citigroup | 34k | $1.4M | 32873% | Dec 2023 |
|
| Swiss National Bank | 23k | $918k | 100% | Dec 2023 |
|
| Barclays | 21k | $858k | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 21k | $835k | 0% | Dec 2023 |
|
| AWM Investment Company | 20k | $805k | 100% | Dec 2023 |
|
| Caption Management | 20k | $805k | 100% | Dec 2023 |
|
| ALPS Advisors | 20k | $784k | 100% | Dec 2023 |
|
| UBS Group | 18k | $716k | 100% | Dec 2023 |
|
| Millennium Management | 14k | $551k | -75% | Dec 2023 |
|
| Credit Suisse | 13k | $517k | 100% | Dec 2023 |
|
| Citadel Advisors | 13k | $503k | -69% | Dec 2023 |
|
| Aspiriant | 12k | $519k | 0% | Mar 2024 |
|
| Cannon Global Investment Management | 12k | $505k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 9.9k | $400k | 5% | Dec 2023 |
|
| State of Wisconsin Investment Board | 9.5k | $382k | 100% | Dec 2023 |
|
| Legal & General Group | 7.7k | $311k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 7.2k | $290k | 100% | Dec 2023 |
|
| Squarepoint Ops | 6.9k | $278k | 100% | Dec 2023 |
|
| Captrust Financial Advisors | 6.1k | $244k | -41% | Dec 2023 |
|
| Simplex Trading | 4.2k | $168k | 100% | Dec 2023 |
|
| Cutler | 3.5k | $3.1k | 100% | Mar 2024 |
|
| Virtus ETF Advisers | 2.5k | $100k | 100% | Dec 2023 |
|
| ADAR1 Capital Management | 1.1k | $44k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 681.00 | $27k | -98% | Dec 2023 |
|
| VisionPoint Advisory Group | 168.00 | $6.8k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 137.00 | $6.0k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 115.00 | $4.6k | 248% | Dec 2023 |
|
| Advisor Group Holdings | 71.00 | $2.9k | 0% | Dec 2023 |
|
| Global Retirement Partners | 70.00 | $3.0k | 100% | Mar 2024 |
|
| Harbour Investments | 5.00 | $201.000000 | 100% | Dec 2023 |
|
Who sold out of Soleno Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| RA Capital Management | Sep 2023 | 1.2M | $37M |
| Fairmount Funds Management | Sep 2023 | 1.1M | $34M |
| Soleus Capital Management | Sep 2023 | 325k | $9.6M |
| Logos Global Management | Sep 2023 | 125k | $3.7M |
| Moore Capital Management | Sep 2023 | 50k | $1.5M |
| Walleye Trading Advisors | Sep 2023 | 46k | $1.4M |
| Maven Securities | Sep 2023 | 25k | $738k |
| Sassicaia Capital Advisers | Sep 2023 | 8.7k | $255k |
| Clayton Partners | Sep 2023 | 7.0k | $207k |